Werewolf Therapeutics gets US FDA fast track designation for its investigational therapy WTX-124 for treatment of cancer: Watertown, Massachusetts Saturday, October 11, 2025, 14:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback